Literature DB >> 28213165

HBVcircle: A novel tool to investigate hepatitis B virus covalently closed circular DNA.

Zhipeng Yan1, Jing Zeng1, Youjun Yu1, Kunlun Xiang1, Hui Hu1, Xue Zhou1, Lili Gu1, Li Wang1, Jie Zhao1, John A T Young2, Lu Gao3.   

Abstract

BACKGROUND & AIMS: Hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) persists as a stable episome in infected hepatocytes and serves as a template for the transcription of all viral genes. Due to the narrow host range of HBV, the development of a robust mouse model that supports cccDNA-dependent viral replication is a key hurdle in the development of novel HBV therapeutics. This study aimed to develop a novel tool to investigate HBV cccDNA.
METHODS: Through minicircle technology, HBVcircle, a recombinant cccDNA, was easily generated and extracted from a genetically engineered E. coli strain. We characterized the performance of HBVcircle in cell culture by transfection and in immunocompetent mice by hydrodynamic injection (HDI).
RESULTS: We demonstrated that HBVcircle formed authentic cccDNA-like molecules in vitro in transiently transfected hepatic cells and in vivo in mouse liver after HDI. HBVcircle supported high levels and persistent HBV replication. In addition, we investigated different factors affecting HBV in vivo replication and persistence, including the host genetic background, vector design and dosage, viral genes and genotypes, and immune activation status. Furthermore, different classes of anti-HBV drugs were also assessed with the HBVcircle system.
CONCLUSION: Compared with previous reported HBV mouse models which employ other viral vectors to introduce overlength HBV genomes, viral gene expression and associated phenotypes are entirely driven by cccDNA-like viral genomes in the HBVcircle mouse model. Therefore, the HBVcircle is a close mimic of cccDNA, and it represents a novel tool for addressing HBV cccDNA related biological questions and for anti-HBV drug discovery. LAY
SUMMARY: To establish a mouse model that supports cccDNA-dependent transcription, a novel tool named HBVcircle, was developed with minicircle technology. HBVcircle formed authentic cccDNA-like molecules in hepatocytes, and supported high levels and persistent HBV replication in vivo. The HBVcircle is a close mimic of cccDNA, and it represents a novel tool for addressing HBV cccDNA related biological questions and for anti-HBV drug discovery.
Copyright © 2017 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-HBV drug discovery; HBV mouse model; Hydrodynamic injection; Minicircle; Recombinant cccDNA

Mesh:

Substances:

Year:  2017        PMID: 28213165     DOI: 10.1016/j.jhep.2017.02.004

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  21 in total

1.  Viral hepatitis: The bumpy road to animal models for HBV infection.

Authors:  Ulrike Protzer
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-04-12       Impact factor: 46.802

Review 2.  Recent advances in the study of hepatitis B virus covalently closed circular DNA.

Authors:  Mengying Ji; Kanghong Hu
Journal:  Virol Sin       Date:  2017-12-21       Impact factor: 4.327

3.  Cre/LoxP-HBV plasmids generating recombinant covalently closed circular DNA genome upon transfection.

Authors:  Robert L Kruse; Xavier Legras; Mercedes Barzi
Journal:  Virus Res       Date:  2020-11-06       Impact factor: 3.303

Review 4.  Animal Models of Hepatitis B Virus Infection-Success, Challenges, and Future Directions.

Authors:  Yongzhen Liu; Stephanie Maya; Alexander Ploss
Journal:  Viruses       Date:  2021-04-28       Impact factor: 5.048

5.  Lost Small Envelope Protein Expression from Naturally Occurring PreS1 Deletion Mutants of Hepatitis B Virus Is Often Accompanied by Increased HBx and Core Protein Expression as Well as Genome Replication.

Authors:  Shuwen Fu; Jing Zhang; Quan Yuan; Qianru Wang; Qiang Deng; Jisu Li; Ningshao Xia; Yongxiang Wang; Yumei Wen; Shuping Tong
Journal:  J Virol       Date:  2021-06-24       Impact factor: 5.103

6.  LINC01431 Promotes Histone H4R3 Methylation to Impede HBV Covalently Closed Circular DNA Transcription by Stabilizing PRMT1.

Authors:  Yang Sun; Yan Teng; Liyuan Wang; Zhaoying Zhang; ChaoJia Chen; Yingchun Wang; Xiaodong Zhang; Peng Xiang; Xiaojia Song; Jinghui Lu; Nailin Li; Lifen Gao; Xiaohong Liang; Yuchen Xia; Zhuanchang Wu; Chunhong Ma
Journal:  Adv Sci (Weinh)       Date:  2022-04-10       Impact factor: 17.521

7.  Exploring the role of NCCR variation on JC polyomavirus expression from dual reporter minicircles.

Authors:  Anne-Sophie L'Honneur; Hervé Leh; Fanny Laurent-Tchenio; Uriel Hazan; Flore Rozenberg; Stéphanie Bury-Moné
Journal:  PLoS One       Date:  2018-06-26       Impact factor: 3.240

Review 8.  Mouse models for hepatitis B virus research.

Authors:  Jeong-Ryul Hwang; Sung-Gyoo Park
Journal:  Lab Anim Res       Date:  2018-09-27

9.  Clinical stage drugs targeting inhibitor of apoptosis proteins purge episomal Hepatitis B viral genome in preclinical models.

Authors:  Michelle P Clark; Thao Huynh; Peter Revill; Marc Pellegrini; Gregor Ebert; Shringar Rao; Liana Mackiewicz; Hugh Mason; Shahla Romal; Michael D Stutz; Sang H Ahn; Linda Earnest; Vitina Sozzi; Margaret Littlejohn; Bang M Tran; Norbert Wiedemann; Elizabeth Vincan; Joseph Torresi; Hans J Netter; Tokameh Mahmoudi
Journal:  Cell Death Dis       Date:  2021-06-23       Impact factor: 8.469

10.  Inhibition of Hepatitis B Virus by AAV8-Derived CRISPR/SaCas9 Expressed From Liver-Specific Promoters.

Authors:  Kun Yan; Jiangpeng Feng; Xing Liu; Hongyun Wang; Qiaohong Li; Jiali Li; Tianmo Xu; Muhammad Sajid; Hafiz Ullah; Li Zhou; Limin Zhou; Yu Chen
Journal:  Front Microbiol       Date:  2021-06-26       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.